Joseph C. Papa (born October 1, 1955) is an American businessman and the chairman and chief executive officer (CEO) of
Bausch & Lomb, a company formed from the initial public offering (IPO) of the eye health business of
Bausch Health Companies Inc.
Early life
Papa received a bachelor's degree in pharmacy from the
University of Connecticut
The University of Connecticut (UConn) is a public land-grant research university in Storrs, Connecticut, a village in the town of Mansfield. The primary 4,400-acre (17.8 km2) campus is in Storrs, approximately a half hour's drive from Hart ...
in 1978, and an MBA degree in marketing and finance from
Northwestern University
Northwestern University is a private research university in Evanston, Illinois. Founded in 1851, Northwestern is the oldest chartered university in Illinois and is ranked among the most prestigious academic institutions in the world.
Charte ...
's
Kellogg Graduate School of Management in 1983.
Career
Papa has been chairman and CEO of
Bausch & Lomb since its IPO in May 2022. He was previously chairman and CEO of
Bausch Health Companies Inc. (formerly
Valeant Pharmaceuticals International, Inc.), having succeeded
J. Michael Pearson
J. Michael Pearson (born 1959) is a Canadian American pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International after being ousted in the aftermath of a report on pharmaceutical pricing publish ...
in those roles in May 2016. Papa resigned as CEO of Bausch Health upon becoming chairman and CEO of Bausch & Lomb in May 2022, but retained his position as chairman of Bausch Health until his resignation on June 23, 2022. Prior to joining Valeant, Papa was the chairman and CEO of
Perrigo
Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax ...
, an American manufacturer of
private label over-the-counter
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescr ...
pharmaceutical
A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and re ...
s, from 2006 to 2016. From December 2004 to October 2006, Papa was chairman and CEO of the pharmaceutical and technologies services of
Cardinal Health, an Ohio health care services company. From 2001 to 2004, he was president and chief operating officer of
Watson Pharmaceuticals
Actavis Generics (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan Inc) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuti ...
, Inc. He has also worked at
Novartis
Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and
Cambridge, Massachusetts, United States (global research).name="novartis.com">https://www.novartis.com/research-development/research-loc ...
and
Pharmacia/
Searle Searle may refer to:
__NOTOC__ Persons
* Searle (surname)
* J. Searle Dawley (1877–1949), American film director, producer, screenwriter, stage actor and playwright
* Searle Turton (born 1979), Canadian politician
Places
* Serle, a comune in Lomb ...
, where he launched the medications
Celebrex
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 inhibitor and nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the pain and inflammation in osteoarthritis, acute pain in adults, rheumatoid arthritis, ankyl ...
,
Diovan, and
Lotrel.
In 2014, he was ranked 47th on Harvard Business Review's "Best Performing CEOs in the World".
Total compensation
In March 2017, it was reported that Papa received US$62.7 million in total compensation for his first eight months of work in 2016.
In March 2020, Bausch Health reported that Papa's gross income for 2019 rose to $17.1 million from $14.7 million in 2018.
In May 2022, Bausch Health reported that Papa’s gross income increased again to $22.9 million, as compared to the $44,617 median compensation of all other Bausch Health employees, reflecting a pay ratio of 513:1.
Personal life
As of May 2015, Papa had been married for 32 years.
References
{{DEFAULTSORT:Papa, Joseph C
Living people
1950s births
American chief executives
University of Connecticut alumni
Kellogg School of Management alumni